US2914563A
(en)
|
1957-08-06 |
1959-11-24 |
Wm S Merrell Co |
Therapeutic composition
|
IT951631B
(it)
|
1971-03-18 |
1973-07-10 |
Richardson Merrell Spa |
Composti utili per la separazione di isomeri ottici geometrici e strutturali e relativo procedimen to di sintesi
|
US4061733A
(en)
|
1976-10-15 |
1977-12-06 |
Narayan Vishwanath Gunjikar |
Veterinary compositions for inducing estrus in animals and method
|
US4729999A
(en)
|
1984-10-12 |
1988-03-08 |
Bcm Technologies |
Antiestrogen therapy for symptoms of estrogen deficiency
|
DE3660489D1
(en)
|
1985-06-08 |
1988-09-15 |
Asta Pharma Ag |
Derivatives of 1,1,2,2-tetramethyl-1,2-bis(2-fluoro-4-hydroxyphenyl) ethane
|
US4820736A
(en)
|
1987-03-20 |
1989-04-11 |
Yale University |
Use of clomiphene to predict fertility in a human female
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
WO1994006762A1
(en)
|
1992-09-15 |
1994-03-31 |
Merrell Dow Pharmaceuticals Inc. |
Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
|
US5776923A
(en)
|
1993-01-19 |
1998-07-07 |
Endorecherche, Inc. |
Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
|
GB9405304D0
(en)
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
AU2638795A
(en)
|
1994-06-17 |
1996-01-15 |
University Of Nebraska Board Of Regents |
In situ gel-forming delivery vehicle for bio-affecting substances, and method of use
|
DE4435368A1
(de)
|
1994-09-22 |
1996-03-28 |
Schering Ag |
Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann
|
EP0844870B1
(en)
|
1995-08-17 |
2001-11-21 |
Csir |
Controlled release products
|
US5773031A
(en)
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
IL120262A
(en)
|
1996-02-28 |
2001-01-28 |
Pfizer |
Droloxifene and derivatives thereof for use in increasing serum testosterone levels
|
ATE277739T1
(de)
|
1996-10-28 |
2004-10-15 |
Gen Mills Inc |
Einbettung und einkapselung von teilchen zur kontrollierten abgabe
|
IL132120A0
(en)
|
1997-04-03 |
2001-03-19 |
Guilford Pharm Inc |
Biodegradable terephthalate polyester-poly (phosphate) polymers compositions articles and methods for making and using the same
|
US6653297B1
(en)
|
1997-07-03 |
2003-11-25 |
Medical College Of Hampton Roads |
Control of selective estrogen receptor modulators
|
US6342250B1
(en)
|
1997-09-25 |
2002-01-29 |
Gel-Del Technologies, Inc. |
Drug delivery devices comprising biodegradable protein for the controlled release of pharmacologically active agents and method of making the drug delivery devices
|
US6413533B1
(en)
|
1998-05-07 |
2002-07-02 |
The University Of Tennessee Research Corporation |
Method for chemoprevention of prostate cancer
|
US20040186185A1
(en)
|
1998-05-07 |
2004-09-23 |
Steiner Mitchell S. |
Method for treatment and chemoprevention of prostate cancer
|
NZ510201A
(en)
|
1998-07-30 |
2002-10-25 |
Stoller Ets |
Treatment of plants with salicylic acid and organic amines
|
US6291505B1
(en)
|
1998-08-07 |
2001-09-18 |
Chiron Corporation |
Estrogen receptor modulators
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
PL352250A1
(en)
|
1999-06-11 |
2003-08-11 |
Watson Pharmaceuticals |
Administration of non-oral androgenic steroids to women
|
CA2321321A1
(en)
|
1999-09-30 |
2001-03-30 |
Isotis B.V. |
Polymers loaded with bioactive agents
|
US6258802B1
(en)
|
1999-10-06 |
2001-07-10 |
Medical College Of Hampton Roads |
Corticoid therapy
|
US20020004065A1
(en)
|
2000-01-20 |
2002-01-10 |
David Kanios |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
NZ534348A
(en)
|
2000-01-28 |
2006-06-30 |
Endorech Inc |
Selective estrogen receptor modulators in combination with estrogens
|
US7067557B2
(en)
|
2000-05-26 |
2006-06-27 |
Harry Fisch |
Methods of treating androgen deficiency in men using selective antiestrogens
|
CA2409647C
(en)
|
2000-05-26 |
2012-07-03 |
Harry Fisch |
Methods of treating androgen deficiency in men using selective antiestrogens
|
CA2416976C
(en)
|
2000-08-11 |
2008-05-20 |
Wyeth |
Treatment of estrogen receptor positive carcinoma with a rapamycin and an antiestrogen
|
US6503894B1
(en)
|
2000-08-30 |
2003-01-07 |
Unimed Pharmaceuticals, Inc. |
Pharmaceutical composition and method for treating hypogonadism
|
US20040192598A1
(en)
|
2000-10-11 |
2004-09-30 |
Laura Kragie |
Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase
|
US6743448B2
(en)
|
2000-12-11 |
2004-06-01 |
Abraham H. Kryger |
Topical testosterone formulations and associated methods
|
CN1954807A
(zh)
|
2001-07-09 |
2007-05-02 |
佐纳根有限公司 |
富含反式克罗米酚的克罗米酚组合物
|
US7173064B2
(en)
|
2001-07-09 |
2007-02-06 |
Repros Therapeutics Inc. |
Methods and compositions with trans-clomiphene for treating wasting and lipodystrophy
|
US6645974B2
(en)
|
2001-07-31 |
2003-11-11 |
Merck & Co., Inc. |
Androgen receptor modulators and methods for use thereof
|
AU2002330031B2
(en)
|
2001-09-21 |
2007-07-05 |
Merck & Co., Inc. |
Androstanes as androgen receptor modulators
|
US20060269611A1
(en)
|
2001-11-29 |
2006-11-30 |
Steiner Mitchell S |
Prevention and treatment of androgen-deprivation induced osteoporosis
|
US7105679B2
(en)
|
2001-12-19 |
2006-09-12 |
Kanojia Ramesh M |
Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
US20050042268A1
(en)
|
2003-07-16 |
2005-02-24 |
Chaim Aschkenasy |
Pharmaceutical composition and method for transdermal drug delivery
|
WO2006019916A1
(en)
*
|
2004-07-14 |
2006-02-23 |
Repros Therapeutics Inc. |
Trans-clomiphene for the treatment of benign prostate hypertrophy, prostate cancer, hypogonadism, elevated triglycerides and high cholesterol
|
US20060293294A1
(en)
|
2004-09-03 |
2006-12-28 |
Hormos Medical Corporation |
Method for treatment or prevention of androgen deficiency
|
BRPI0606528A8
(pt)
|
2005-02-04 |
2018-03-13 |
Repros Therapeutics Inc |
composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma
|
AU2006213856B2
(en)
|
2005-02-11 |
2011-03-17 |
Regeneron Pharmaceuticals, Inc. |
Therapeutic combination of a VEGF antagonist (VEGF trap) and an anti-hypertensive agent
|
RU2413508C2
(ru)
*
|
2005-03-22 |
2011-03-10 |
Репрос Терапьютикс Инк. |
Режимы дозирования транс-кломифена
|
EP1896134A2
(en)
|
2005-06-13 |
2008-03-12 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions for treating degenerative bone disorders
|
JP2009503096A
(ja)
|
2005-08-05 |
2009-01-29 |
リプロス セラピューティクス インコーポレイテッド |
クロミフェンを用いる女性不妊症を処置するための方法および組成物
|
US7613937B2
(en)
|
2005-10-31 |
2009-11-03 |
Hewlett-Packard Development Company, L.P. |
Method and apparatus for utilizing a microcontroller to provide an automatic order and timing power and reset sequencer
|
WO2007095716A1
(en)
|
2006-02-23 |
2007-08-30 |
Iomedix Sleep International Srl |
Compositions and methods for the induction and maintenance of quality sleep
|
EP1829534A1
(en)
|
2006-03-02 |
2007-09-05 |
Laboratorios Del Dr. Esteve, S.A. |
Use of compounds binding to the sigma receptor for the treatment of metabolic syndrome
|
ES2427924T3
(es)
|
2006-06-30 |
2013-11-04 |
Merck Sharp & Dohme Corp. |
Biomarcador IGFBP2
|
ES2381175T3
(es)
|
2007-06-26 |
2012-05-23 |
Media Patents, S. L. |
Dispositivo para gestionar grupos multidifusión
|
US8106037B2
(en)
|
2007-08-03 |
2012-01-31 |
The Brigham And Women's Hospital, Inc. |
Identification and treatment of estrogen responsive prostate tumors
|
EP2826475B1
(en)
|
2007-10-16 |
2019-03-20 |
Repros Therapeutics Inc. |
Trans-clomiphene for treating diabetes in hypogonadal men
|
US20100111901A1
(en)
|
2008-11-03 |
2010-05-06 |
Auspex Pharmaceuticals, Inc. |
Triazole inhibitors of aromatase
|
TWI458478B
(zh)
*
|
2008-11-07 |
2014-11-01 |
Repros Therapeutics Inc |
用於代謝症候群與第2型糖尿病的反式氯米芬
|
US20100144687A1
(en)
|
2008-12-05 |
2010-06-10 |
Glaser Rebecca L |
Pharmaceutical compositions containing testosterone and an aromatase inhibitor
|
UA113291C2
(xx)
*
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
WO2013020215A1
(en)
|
2011-08-09 |
2013-02-14 |
Adams Kenneth W |
Use of aromatase inhibitor or estrogen blocker for increasing spermatogenesis or testosterone levels in males
|
US20150031656A1
(en)
|
2012-02-29 |
2015-01-29 |
Repros Therapeutics Inc. |
Combination therapy for treating androgen deficiency
|
SG10201704820SA
(en)
|
2012-08-21 |
2017-07-28 |
Repros Therapeutics Inc |
Trans-clomiphene formulations and uses thereof
|
CN103351304B
(zh)
|
2013-07-01 |
2015-12-09 |
暨明医药科技(苏州)有限公司 |
一种克罗米芬的合成方法
|